ADVENTRX logo
Company Products Clinical Trials Partners Investors Resources Contact
Company

MISSION & STRATEGY

STRATEGY

CLINICAL & REGULATORY STRATEGY

COMMERCIALIZATION

HISTORY

TEAM

HISTORY

ADVENTRX Pharmaceuticals, Inc. is the result of a merger, effective October 10, 2000, between BioQuest, Inc., a public company, and Biokeys, Inc., a privately held entity. The two companies adjusted outstanding shares, options, and warrants on a 50/50 basis.

In June 2003, the Company was renamed ADVENTRX Pharmaceuticals, Inc.

In April 2004, the Company announced that its common stock began listing on the American Stock Exchange (Amex®) under the ticker symbol "ANX".



COMPANY | PRODUCTS | CLINICAL TRIALS | PARTNERS | INVESTORS | RESOURCES | CONTACT
HOME | CAREERS | SEARCH | SITE MAP | HELP | LEGAL
© Copyright 2008 ADVENTRX Pharmaceuticals

Search Careers Back to homepage